We're developing innovative treatments for Alzheimer's disease.

Pipeline

Pipeline

Program Pipeline Target Development Stage
DISCOVERY LEAD
OPTIMIZATION
IND-ENABLING EARLY
CLINICAL
LATE
CLINICAL

AMYLOID

AS-603

Aβ&Tau

AS-611

Non-disclosed

GLIA

AS-403

Non-disclosed

AS-402

Non-disclosed

Homeostasis

AS-921

ASM & Ghrelin